Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1A | O00555 | 2/20 | 0.64 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.64 |
| ▸ | CACNB1 | Q02641 | 2/20 | 0.64 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.44 |
| ▸ | CCR2 | P41597 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3888401 | 0.83 | CACNA2D1 (0.73) | CACNA1ACACNA2D1CACNB1HPGDSMN1; SMN2 | |
| SCHEMBL3888407 | 0.80 | CACNA2D1 (0.61) | CACNA1ACACNA2D1CACNB1HPGDSMN1; SMN2 | |
| SCHEMBL10525548 | 0.79 | L3MBTL1 (0.54) | CACNA1ACACNA2D1CACNB1AGTR2KDM4E | |
| SCHEMBL4182908 | 0.79 | CACNA2D1 (1.00) | CACNA1ACACNA2D1CACNB1HPGDSMN1; SMN2 | |
| SCHEMBL3862187 | 0.74 | KDM4E (0.70) | CACNA1ACACNA2D1CACNB1KDM4ETSHR | |
| SCHEMBL124103 | 0.73 | L3MBTL1 (0.55) | SMN1; SMN2KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL9581725 | 0.73 | L3MBTL1 (0.55) | AGTR2KDM4EATML3MBTL1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL2858521 | 0.72 | L3MBTL1 (0.54) | SMN1; SMN2KDM4EATML3MBTL1ALDH1A1 | |
| SCHEMBL3654006 | 0.71 | L3MBTL1 (0.56) | AGTR2KDM4ETSHRATML3MBTL1 | |
| SCHEMBL14917669 | 0.71 | AGTR2 (0.62) | AGTR2KDM4EATML3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1670775-A4 | PIPERAZINE SUBTITUTED COMPOUNDS USED AS CALCIUM CHANNEL BLOCKERS | NEUROMED PHARMACEUTICALS LTD (CA) | 2009-04-22 | — | — | EP | claimed |
| JP-2007504174-A | — | — | 2007-03-01 | — | — | JP | claimed |
| EP-1670775-A1 | PIPERAZINE SUBTITUTED COMPOUNDS USED AS CALCIUM CHANNEL BLOCKERS | Neuromed Pharmaceuticals, Ltd. (CA) | 2006-06-21 | — | — | EP | claimed |
| WO-2005021523-A1 | PIPERAZINE SUBSTITUTED COMPOUNDS USED AS CALCIUM CHANNEL BLOCKERS | NEUROMED TECHNOLOGIES, INC. (CA) | 2005-03-10 | — | — | WO | claimed |